CAVALIERE, Caterina
 Distribuzione geografica
Continente #
NA - Nord America 396
EU - Europa 276
AS - Asia 23
Totale 695
Nazione #
US - Stati Uniti d'America 396
IE - Irlanda 137
SE - Svezia 95
DE - Germania 20
CN - Cina 10
IT - Italia 10
SG - Singapore 9
GB - Regno Unito 4
PL - Polonia 4
VN - Vietnam 4
BE - Belgio 3
FI - Finlandia 2
FR - Francia 1
Totale 695
Città #
Chandler 167
Dublin 137
Nyköping 65
Ashburn 27
Princeton 21
Bremen 19
Medford 17
Des Moines 16
Wilmington 9
Seattle 8
Falls Church 6
Singapore 6
Dong Ket 4
Leeds 4
Warsaw 4
Brussels 3
Castellammare Di Stabia 3
Santa Clara 3
Beijing 2
Brindisi 2
Helsinki 2
Shenyang 2
Washington 2
Jacksonville 1
Messina 1
Mountain View 1
Munich 1
Nanchang 1
Nanjing 1
Norwalk 1
Reims 1
Taizhou 1
Yicheng 1
Totale 539
Nome #
Axitinib after Sunitinib in metastatic renal cancer: Preliminary results from Italian "Real-World" SAX Study 52
Role of DNA repair machinery and p53 in the testicular germ cell cancer: A review 50
Sequential treatment with pazopanib and everolimus in metastatic renal cell carcinoma 47
Paediatric arterial ischaemic stroke and cerebral sinovenous thrombosis. First report from the Italian Registry of Pediatric Thrombosis (R. I. T. I., Registro Italiano Trombosi Infantili). 44
Epithelial-mesenchymal transition in prostate cancer: An overview 42
From clinical trials to the front line: Vinflunine for treatment of urothelial cell carcinoma at the National Cancer Institute of Naples 41
Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: Clinical and prognostic implications 40
Endocrine disruptors and female cancer: Informing the patients (Review) 39
Metabolic syndrome, endocrine disruptors and prostate cancer associations: Biochemical and pathophysiological evidences 39
Nomegestrol acetate/estradiol hormonal oral contraceptive and breast cancer risk 36
Rectal/urinary toxicity after hypofractionated vs. Conventional radiotherapy in high risk prostate cancer: Systematic review and meta analysis 35
Rectal/urinary toxicity after hypofractionated vs conventional radiotherapy in low/intermediate risk localized prostate cancer: Systematic review and meta analysis 35
Correction: Metabolic syndrome, endocrine disruptors and prostate cancer associations: Biochemical and pathophysiological evidences [Oncotarget, 8, (2017) (30606-30616)] doi 10.18632/oncotarget.16725 35
Very early PSA response to abiraterone in mCRPC patients: A novel prognostic factor predicting overall survival 34
Predictive Comprehensive Geriatric Assessment in elderly prostate cancer patients: The prospective observational scoop trial results 33
Serum and tissue markers in colorectal cancer: State of art 31
Corrigendum: Pazopanib in metastatic renal cancer: A "real-world" experience at national cancer institute "Fondazione G. Pascale" [Front. Pharmacol., 7, 287, (2016)] doi: 10.3389/fphar.2016.00287 31
Carcinogenetic mechanisms of endocrine disruptors in female cancers (Review) 28
Pazopanib in metastatic renal cancer: A "real-world" experience at National Cancer Institute "Fondazione G. Pascale" 28
Totale 720
Categoria #
all - tutte 4.500
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.500


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 1 0 0
2020/202145 0 0 2 0 1 0 0 24 9 4 0 5
2021/2022136 0 1 0 0 6 9 7 4 1 7 44 57
2022/2023454 24 44 18 55 34 45 7 28 180 3 12 4
2023/202475 8 11 2 24 7 4 4 9 0 0 0 6
2024/20259 3 6 0 0 0 0 0 0 0 0 0 0
Totale 720